title: Residual neuromuscular blockade in myotonic dystrophy: lessons unlearned and sugammadex.
authors.forename: P A
authors.initials: PA
authors.lastname: Stewart
authors.forename: S
authors.initials: S
authors.lastname: Phillips
authors.forename: H D
authors.initials: HD
authors.lastname: de Boer
mesh_terms: D000402:Airway Obstruction / Q000139:chemically induced; D000762:Anesthesia Recovery Period; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D007442:Intubation, Intratracheal; D016343:Monitoring, Intraoperative; D008991:Monitoring, Physiologic; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009223:Myotonic Dystrophy / Q000150:complications*; D019148:Neuromuscular Blockade / Q000009:adverse effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000009:adverse effects / Q000037:antagonists & inhibitors; D011247:Pregnancy; D000077122:Sugammadex; D009435:Synaptic Transmission / Q000187:drug effects; D055815:Young Adult; D047408:gamma-Cyclodextrins / Q000009:adverse effects*
chemical_list: D002800:Cholinesterase Inhibitors; D018727:Muscarinic Antagonists; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex